Hierro intravenoso en la terapia del síndrome de piernas inquietas / Intravenous iron for restless legs syndrome. Report of five cases
Rev. méd. Chile
;
147(12): 1569-1571, dic. 2019.
Article
in Spanish
| LILACS
| ID: biblio-1094191
RESUMEN
Restless legs syndrome (RLS) may severely affect the quality of life of patients. A deficient iron incorporation into the central nervous system has an important role in the pathophysiology of RLS. Severely affected patients may not respond to current therapeutic options. We report a preliminary experience with five patients with severe RLS and low serum ferritin levels who did not improve with oral iron. All were treated with 1 g of intravenous iron carboxymaltose. They experienced a marked improvement in symptoms, evident even during the first week of therapy that had persistent after up to two years of follow-up. A significant change in the RLS severity scale was observed after intravenous iron. Serum ferritin levels increased in all of them. Intravenous iron could be a therapeutic option for patients with severe RLS.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Restless Legs Syndrome
/
Administration, Intravenous
/
Iron
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2019
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Fundación Diagnosis/CL
/
Universidad de Chile/CL
Similar
MEDLINE
...
LILACS
LIS